skip to Main Content

Discovery of New Source of Cancer Antigens May Expand Cancer Vaccine Capabilities

Discovery of New Source of Cancer Antigens May Expand Cancer Vaccine Capabilities

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University’s Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.

The mindset is simple, according to Johnston. Treat cancer just like an infectious disease. So, when his team looked deep within tumors, their research gold was discovering 200,000 cancer neoantigens, the components of cancer vaccines, that had been missed by others. They also found that enough of these neoantigens occurred repeatedly in different tumors that it might be possible to make one vaccine for all tumors. Read more . . . 


Back To Top